GHK-Cu + KPV + BPC-157 + TB-500 Blend
Proprietary peptide blends popularised by BioLongevity Labs that combine four complementary compounds into a single protocol. GLOW is the skin and anti-aging focused variant; KLOW adds higher concentrations for recovery and systemic effects. Both went viral on TikTok in 2025 and remain among the most discussed stacks in the community.
01 — Research Summary
GLOW / KLOW has developed a substantial research portfolio across multiple domains. The evidence base spans animal models, cell studies, and in some cases early human data — providing a multi-layered picture of this compound's mechanisms and potential applications.
GHK-Cu: master gene regulator. The GHK-Cu component alone modulates over 4,000 human genes, shifting expression toward a younger phenotype. Combined with the other three compounds, gene-level anti-aging effects are expected to be additive.
KPV: potent gut anti-inflammatory. As a C-terminal fragment of alpha-MSH, KPV acts on melanocortin receptors in the gut mucosa to reduce inflammation, protect the epithelial barrier, and modulate immune response — complementing BPC-157's gut healing action.
BPC-157: repair signalling. BPC-157 drives the angiogenesis and growth factor signalling (EGR-1, VEGF) that initiates and sustains tissue repair — providing the molecular foundation on which TB-500's cell migration effects act.
TB-500: cellular machinery. By regulating actin polymerisation, TB-500 enables the rapid cell migration that physically executes the repair signalled by BPC-157 — their mechanisms are directly complementary rather than overlapping.
Synergistic mechanism design. The GLOW/KLOW formulation is based on the hypothesis that GHK-Cu (gene reset + collagen), KPV (gut + skin inflammation), BPC-157 (signalling + angiogenesis), and TB-500 (cell movement + anti-fibrosis) cover every phase of repair without mechanistic overlap.
02 — Mechanism of Action
Understanding the mechanism helps explain why GLOW / KLOW produces the range of effects documented in both research and community reports. The compound operates through several interconnected pathways simultaneously.
GHK-Cu acts as the genomic foundation of the blend — shifting gene expression across 4,000+ genes toward a youthful pattern. It simultaneously drives collagen synthesis, VEGF-mediated angiogenesis, and antioxidant enzyme upregulation.
KPV (Lys-Pro-Val) acts on melanocortin receptors to suppress gut and skin inflammation. It specifically targets the mucosal barriers where chronic low-grade inflammation is most damaging — providing the anti-inflammatory foundation for the other components to work effectively.
BPC-157 drives the molecular signalling cascade of tissue repair — activating EGR-1, upregulating VEGF, stimulating nitric oxide production, and initiating angiogenesis. It provides the cellular instructions that direct and coordinate the healing response.
TB-500 provides the physical cellular machinery to execute the repair signalled by BPC-157. By regulating actin, it enables fibroblasts, endothelial cells, and immune cells to migrate rapidly to the repair site — turning molecular signals into physical tissue reconstruction.
All four components independently inhibit TNF-α and other pro-inflammatory cytokines. The combined anti-inflammatory effect of the blend is significantly greater than any single component, creating an optimal environment for clean regeneration over scar formation.
The multi-pathway mechanism of GLOW / KLOW explains its broad range of documented effects. Rather than acting on a single target, it engages multiple biological systems simultaneously — which is both the source of its versatility and the reason dosing and cycling matter.
03 — Dosing Protocols
The following protocols are drawn from published research literature and community-reported experience. Individual responses vary significantly. Always start at the lower end of the dose range.
| Protocol | Dose | Frequency | Duration | Notes |
|---|---|---|---|---|
| GLOW blend — standard | 2 mg total blend | 3× per week | 8–12 weeks | GHK-Cu/KPV dominant ratios for skin and anti-aging focus. |
| KLOW blend — standard | 4 mg total blend | 3× per week | 8–12 weeks | Higher BPC-157/TB-500 ratios for recovery and systemic effects. |
| GLOW blend — maintenance | 1–2 mg | 2× per week | Ongoing | Lower frequency for ongoing skin and longevity maintenance. |
| KLOW blend — acute injury | 4–6 mg | Daily for 2 weeks | Then reduce | Higher loading dose for acute injury protocols. |
Blend ratios: GLOW typically contains higher GHK-Cu and KPV concentrations; KLOW contains higher BPC-157 and TB-500. Exact ratios vary by vendor — always request CoA documentation. Reconstitution: Follow vendor-specific instructions. Standard bacteriostatic water reconstitution applies. Refrigerate and use within 28 days. Note: Purchasing from a reputable vendor with third-party testing is especially important for blends, where cutting individual components is harder to detect.
All dosing information is drawn from published research and community protocols for educational purposes only. GLOW / KLOW is not FDA-approved for human therapeutic use. Consult a licensed healthcare professional before initiating any peptide protocol.
04 — Community Experiences
The GLOW and KLOW blends generated some of the most viral peptide content of 2025, bringing the compounds to mainstream audiences well beyond the traditional research community. Community discussion is high-volume and generally very positive, with a particular focus on sourcing quality and vendor due diligence. The following links surface real discussions from public research and wellness communities. These are anecdotal reports — not clinical evidence — and results vary significantly between individuals.
These are user-reported experiences from public forums. They are not endorsed by Whats That Peptide and should not be interpreted as clinical evidence of efficacy or safety. Individual results vary. Always consult a healthcare professional before starting any peptide protocol.
"The skin results are genuinely the most dramatic I've seen from anything. Texture, firmness, the fine lines around my eyes — all noticeably better. The four-compound approach seems to work better than running GHK-Cu alone..."
"The KLOW blend recovered my knee faster than the Wolverine stack did 2 years ago for my shoulder. The addition of GHK-Cu and KPV seems to add something the classic BPC+TB combo doesn't have. Would choose KLOW over Wolverine for future injuries..."
"Added GLOW to my NAD+ and Epithalon cycle. The combination feels comprehensive in a way I haven't experienced with individual compounds. Bloodwork improving across the board and skin is the best it's been in a decade at 54..."
"The main risk with blends is vendor underdosing individual components. BioLongevity Labs is the originator and has the most transparent CoA process. Third-party test whatever you buy — especially with blends where it's harder to detect cutting..."